Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0354388 Respirable Agglomerates of Porous Carrier Particles and Micronized Drug
Embodiments of the present invention provide a dry powder composition comprising porous carrier particles associated with one, two, three or more micronized...
2016/0354387 PHARMACEUTICAL COMPOSITION BASED ON A HEPATOPROTECTOR AND A PREBIOTIC, AND PRODUCTION AND APPLICATION THEREOF
The invention relates to medicine, hepatology and pharmacology and can be used for producing and using a pharmaceutical composition based on a hepatoprotector...
2016/0354386 COMPOSITIONS AND METHODS FOR REDUCING BODY FAT
The present invention relates to compositions, such as bimatoprost, latanoprost and travoprost, and methods to reduce fat in the body of an individual, for...
2016/0354385 METHOD TO ENHANCE TISSUE REGENERATION
The present invention provides for compositions and methods for modulating tissue growth using tissue growth modulators, which are agents that either enhance...
2016/0354384 ENHANCED BIMATOPROST OPHTHALMIC SOLUTION
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous...
2016/0354383 PROSTAGLANDIN AND VASOCONSTRICTOR PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
Compositions containing a prostaglandin agent and a vasoconstrictor agent for ophthalmic applications are provided as well as methods of treating ophthalmic...
2016/0354382 GAMMA-SECRETASE INHIBITION REDUCE APOC3 LEVELS AND PLASMA TRIGLYCERIDES
A method of reducing a subject's plasma triglyceride level, comprising administering to a subject in need thereof a gamma-secretase inhibitor in an amount...
2016/0354381 DNA-PK INHIBITORS
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said...
2016/0354380 TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN
The present invention relates to methods for preventing or treating of metabolic disorders and related conditions, such as in certain patient groups.
2016/0354379 COMPOUNDS AND COMPOSITIONS FOR TREATING CHEMICAL WARFARE AGENT-INDUCED INJURIES
Compounds and compositions for treating injuries caused by exposure to chemical warfare agents are described herein.
2016/0354378 Composition for Preventing and Treating Acetaminophen Inducing Hepatotoxicity Containing...
The present invention relates to a composition for the prevention and treatment of liver toxicity originated from acetaminophen comprising TNP ...
2016/0354377 SUBSTITUTED PYRAZOLO[3,4-D]PYRIMIDINES AND USES THEREOF
Presented herein are novel therapeutic compounds and methods of using the same for the treatment of cancers.
2016/0354376 Compositions comprising phosphodiesterase inhibitors for use in the treatment of a solid tumor in a human patient
The present invention is related to a composition comprising a phosphodiesterase inhibitor, such as anagrelide or a salt thereof, for use in the treatment of a...
2016/0354375 CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH...
The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1.delta.) and to the use of said inhibitors in the treatment of...
2016/0354374 SUBSTITUTED DIAMINOPYRIMIDYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
Provided herein are diaminopyrimidyl Compounds having the following structures: ##STR00001## wherein X, L, R.sup.1, and R.sup.2 are as defined herein,...
2016/0354373 METHODS OF TREATING ACUTE T CELL LEUKEMIA
The present invention is directed to methods of treating T-cell acute lymphoblastic leukemia. This method involves selecting a subject having T-cell acute...
2016/0354372 COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS
The present disclosure provides methods for treating neurological disorders, generally involving modulating protein kinase D1 (PKD1) activity levels in a...
2016/0354371 LIPID-BASED COMPOSITIONS OF ANTIINFECTIVES FOR TREATING PULMONARY INFECTIONS AND METHODS OF USE THEREOF
A system for treating or providing prophylaxus against a pulmonary infection is disclosed comprising: a) a pharmaceutical formulation comprising a mixture of...
2016/0354370 METHOD FOR TREATING A PROTOZOAL INFECTION
Patients inflicted with various clustering chronic diseases require treatment with multiple drugs having distinct mechanisms of action. Accordingly, patients...
2016/0354369 FORMULATIONS FOR ARIPIPRAZOLE DELIVERY TRANSDERMALLY
Formulations for topical application of aripiprazole are provided. The formulations, when applied topically to the skin of a subject, provide a therapeutic...
2016/0354368 TOPICAL FORMULATIONS FOR DELIVERY OF HEDGEHOG INHIBITOR COMPOUNDS AND USE THEREOF
Compositions for topical administration of a hedgehog inhibitor compound are described. In one embodiment, the hedgehog inhibitor compound is patidegib and the...
2016/0354367 Stem Cell Modulation II
Disclosed are methods and compositions for modulating cancer stem cells. More particularly, the present invention discloses the use of protein kinase C theta...
2016/0354366 NOVEL USE OF TRIMETAZIDINE AS A HEPATOPROTECTIVE MEDICINE IN PREVENTION AND TREATMENT OF LIVER DISEASES AND...
This present invention discloses a new use of trimetazidine as a hepatoprotective drug in prevention and treatment of liver diseases, wherein trimetazidine is...
2016/0354365 Treating Pain In Patients With Hepatic Impairment
An extended release composition for an analgesic active pharmaceutical ingredient which may be an opioid, preferably hydrocodone as the only active ingredient....
2016/0354364 Pharmaceutical Compositions
Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist,...
2016/0354363 LIQUID NALOXONE SPRAY
The invention provides stable liquid formulations containing naloxone, a pharmaceutically acceptable salt or a derivative thereof. The invention further...
2016/0354362 COMPOSITIONS FOR TREATING CMT AND RELATED DISORDERS
The present invention relates to compositions and methods for the treatment of the Charcot-Marie-Tooth disease and related disorders.
2016/0354361 NOVEL USE OF ARYL-QUINOLIN DERIVATIVES AS INHIBITORS OF VASCULOGENIC MIMICRY
Aryl-quinolin derivatives for use in inhibiting vasculogenic mimicry, treating diseases characterized by abnormal vascular morphology or function and/or by the...
2016/0354360 NICOTINE LOZENGE
A nicotine lozenge provided herein includes a body that is partially or wholly receivable in an oral cavity. The body includes a soluble-fiber matrix and...
2016/0354359 COMPOSITION COMPRISING NOR-ADRENALINE AND A NET INHIBITOR FOR ADMINISTERING TO A BRAIN-DEAD, HEART-BEATING...
A composition, an infusion solution, a method for treatment, and a kit for intravascular administration for treatment of a brain-dead, heart-beating,...
2016/0354358 COMPOSITIONS AND METHODS FOR DRUG SENSITIZATION OF PARASITES
Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a...
2016/0354357 METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
Disclosed herein are compositions and methods for treating a sigma-2 receptor-mediated condition or disorder, including treating one or more symptoms of a...
2016/0354356 ORALLY DISINTEGRATING COMPOSITIONS
An orally disintegrating dosage form of a proton pump inhibitor, methods for its production and use thereof are provided. The dosage form includes a plurality...
2016/0354355 DEUTERIUM-ENRICHED PIOGLITAZONE
The present application describes deuterium-enriched pioglitazone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
2016/0354354 DEMETHYLPENCLOMEDINE ANALOGS AND THEIR USE AS ANTI-CANCER AGENTS
This disclosure concerns novel demethylpenclomedine analogs. Also disclosed are pharmaceutical compositions and methods for using such compositions to treat...
2016/0354353 TRIVALENT CHROMIUM COMPOUNDS, COMPOSITIONS AND METHODS OF USE
The present invention provides chromium compounds, specifically chromium dinicocysteinate, which possess the ability to improve insulin sensitization, glucose...
2016/0354352 METHOD OF TREATING INFLAMMATORY BOWEL DISEASE COMPRISING ADMINISTERING A PHARMACEUTICAL COMPOSITION COMPRISING...
Provided is a method of treating inflammatory bowel disease comprising administering a pharmaceutical composition comprising a 6-aminopyridin-3-ol compound or...
2016/0354351 SOLID STATE FORMS OF VEMURAFENIB HYDROCHLORIDE
Provided herein are solid state forms of Vemurafenib hydrochloride, processes for preparing the solid state forms, as well as pharmaceutical compositions and...
2016/0354350 COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO INCREASED EOSINOPHILS
Disclosed herein are methods of treating diseases associated with increased numbers of eosinophils basophils, and/or neutrophils with R(+) pramipexole.
2016/0354349 OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE
The present invention relates to topical formulations comprising a compound of the following formula: ##STR00001## for treating ocular neovascularization. The...
2016/0354348 METHODS FOR PROPHYLATIC APPETITE SUPPRESSION
Pharmaceutical formulations comprise sustained-release zonisamide. Methods of preparing such pharmaceutical formulations involve intermixing zonisamide with a...
2016/0354347 Nuclear Transport Modulators and Uses Thereof
The present invention relates to compounds of formula I: ##STR00001## and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the...
2016/0354346 ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR TREATING SKIN DISEASES AND...
The present invention relates to method for treating skin diseases and skin conditions in a subject in need of such treatment, which comprises administering a...
2016/0354345 METHOD FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH A REDUCED DENSITY OF INTERFERON RECEPTORS
The invention relates to medicine, in particular, to a method for preventing and/or treating a disease associated with a reduced density of interferon...
2016/0354344 ANTI-CANCER COMPOSITIONS AND METHODS
Compositions and pharmaceutical compositions including one or more selenium-containing COX-2 inhibitors are provided according to aspects of the present...
2016/0354343 METHODS OF TREATING ALZHEIMER'S DISEASE AND PHARMACEUTICAL COMPOSITIONS THEREOF
The present invention describes methods of treating dementia comprising administering an effective daily dose of ...
2016/0354342 COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACID-RELATED GASTROINTESTINAL DISORDERS CONTAINING A DITHIOLANE...
A treatment for acid related gastrointestinal disorders. The methods and compounds described include gastric acid secretion inhibitors in combination with...
2016/0354341 THERAPEUTIC FORMULATIONS AND METHODS
The invention provides compositions and methods for treating cyanide poisoning.
2016/0354340 LIPOIC ACID CHOLINE ESTER COMPOSITIONS AND METHODS OF USE
Provided herein are pharmaceutical compositions comprising a therapeutically effective amount of lipoic acid choline ester or derivatives thereof and a...
2016/0354339 C-MYC as a Biomarker for Tumor Sensitivity to Treatment with RNA Polymerase II Inhibition
Systems and methods for determining whether a cancer patient may respond to inhibition of RNA polymerase II as a treatment for the patient are provided....
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.